The Department of Health and Human Services announced the next COVID-19 Medicaid Provider call will take place on December 15 at noon (Central).  

Also in Nebraska, the Department of Health and Human Services (DHHS) updated the Janssen COVID-19 Vaccine Administration – Booster – Code: 0034A — $37.25 (effective November 2, 2021). DHHS also published its Provider Bulletin 21-21 – November 2021 COVID-19 Vaccines Updates, including COVID-19 booster doses and COVID-19 vaccinations for children. For questions, contact Medicaid.

Finally in Nebraska, the COVID rates have been added and been moved from the right-hand navigation list to the main list on the Department of Health and Human Service Medicaid Provider Rates and Fee Schedules website.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Effective November 9, the Department of Health and Human Services published the COVID Ad-Hoc Fee Schedule Booster – Pediatric Vaccine Update.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy published the November 8 meeting agenda and the September 13 draft meeting minutes. The November 8 meeting will be in-person and available to the public via WEBEX; see the agenda for details. 

Also in Nebraska, the Department of Health and Human Services announced the next weekly COVID-19 Medicaid Provider call will take place on November 17 at noon (Central). 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Department of Health and Human Services announced the next weekly COVID-19 Medicaid Provider call will take place on November 3 at noon (Central).

Also in Nebraska, the Department of Health and Human Services added the September 2021 DUR Board draft meeting minutes for approval to the website. Other materials for the DUR Board November 9, 2021, meeting include the agenda and DUR Policy Statements (as of July 2021).

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Dept. of Health and Human Services has posted the DUR Board November 9, 2021, meeting agenda and DUR Policy Statements (as of July 2021); see links below.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

On October 13, Gov. Pete Ricketts (R) signed Executive Order No. 21-15 — Further Health Care Workforce Capacity, including language waiving “Neb. Rev. Stat. § 38-2866.01 and its implementing regulations… to permit pharmacists to have any number of pharmacist interns and pharmacy technicians under their supervision insofar as they determine it necessary within their professional discretion when administering vaccinations…”. It took immediate effect and will remain in effect until December 31, 2021.

Also in Nebraska, the Department of Health and Human Services (DHHS) announced the next weekly COVID-19 Medicaid Provider call will take place on October 20 at noon (Central).

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The 471-000-540 Nebraska Medicaid Practitioner Fee Schedule for Injectables was updated effective October 1.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Effective October 1, all Medicaid beneficiaries will automatically receive full Medicaid benefits, including dental, vision and over-the-counter drugs as part of the Medicaid Expansion program. A new Medicaid card will not be needed for people who have current Medicaid coverage. Recall this change to the Medicaid Expansion program occurs as a result of the Department of Health and Human Services’ notice not to implement the Heritage Health Adult (HHS) demonstration that would have required engagement in wellness, personal responsibility and community engagement activities to quality for full Medicaid benefits.

Also in Nebraska, the Department of Health and Human Services (DHHS) announced the next weekly COVID-19 Medicaid Provider call will take place on October 6 at noon.  Information to access the call has been posted on the DHHS website.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Department of Health and Human Services issued a Health Alert Network Update notifying healthcare providers and facilities that COVID-19 monoclonal antibody (mAb) therapy has a new indication for post-exposure prophylaxis via emergency use authorization.  As of September 13, the US Government began allocating mAb therapy; infusion sites will no longer order mAb therapy directly from distributors. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.